Table 1 General characteristics of the subjects

	Control (n=9)	Theracurmin CR-033P (n=9)	Total (n=18)	p-value*2)
Age (yr)	41.0±2.51)	40.9±2.1	40.94±1.61	0.9736
Height (cm)	164.4±2.0	165.7±3.5	165.03±1.95	0.7391
Weight (kg)	60.1±3.1	60.9±2.8	60.54±2.04	0.8513
BMI (kg/m2)	22.2±1.0	22.1±0.6	22.17±0.54	0.9441
SPB (mmHg)	118.0±5.1	119.4±3.8	118.72±3.11	0.8242
DPB (mmHg)	76.3±4.8	75.3±3.7	75.83±2.94	0.8709
Bpm	72.9±1.2	75.8±4.8	74.33±2.40	0.5697
Total cholesterol (mg/dL)	193.6±13.6	223.3±12.6	208.44±9.70	0.1283
LDL-cholesterol (mg/dL)	113.2±10.7	140.7±11.4	126.94±8.27	0.0976
HDL-cholesterol (mg/dL)	67.2±4.7	59.7±3.5	63.44±2.97	0.2121
Triglycride (mg/dL)	72.9±8.7	117.3±24.1	95.11±13.54	0.1019

Values are presented as mean±standard deviation.
Asterisk indicates significant of difference between control and Theracurmin^® CR-033P using Student t-test.